| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/20/2009 | CN101433669A Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 05/20/2009 | CN101433639A Composition with function for alleviating eyestrain and preparation method thereof |
| 05/20/2009 | CN101433638A Composition with function for alleviating eyestrain and preparation method thereof |
| 05/20/2009 | CN101433637A Composition with function for alleviating eyestrain and preparation method thereof |
| 05/20/2009 | CN101433636A Composition with function for alleviating eyestrain and preparation method thereof |
| 05/20/2009 | CN101433635A Composition with function for alleviating eyestrain and preparation method thereof |
| 05/20/2009 | CN101433574A Composition with function for alleviating eyestrain and preparation method thereof |
| 05/20/2009 | CN101433567A Clinical novel use of soft capsule for removing thromboembolism |
| 05/20/2009 | CN101433519A Azithromycin eye drops and preparation method thereof |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488557C Use of Chinese medicinal composition in preparing medicament for relieving vision fatigue |
| 05/20/2009 | CN100488494C Ophthalmologic Chinese medicine compound preparation, extracting and making methods and use thereof |
| 05/19/2009 | US7534863 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 05/19/2009 | US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 05/19/2009 | US7534802 Compounds having 4-pyridylalkylthio group as substituent |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534436 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/19/2009 | CA2585691C Enhanced bimatoprost ophthalmic solution |
| 05/19/2009 | CA2463947C Montelukast granule formulation |
| 05/19/2009 | CA2388728C Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina |
| 05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/14/2009 | WO2009061910A1 Anti-factor b antibodies and their uses |
| 05/14/2009 | WO2009061830A1 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor |
| 05/14/2009 | WO2009061811A1 Substituted cyclopentanes having prostaglanding activity |
| 05/14/2009 | WO2009061721A1 Complement c1q inhibitors for the prevention and treatment of glaucoma |
| 05/14/2009 | WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 05/14/2009 | WO2009060609A1 Method for producing microcapsule using solid fat |
| 05/14/2009 | WO2009060493A1 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field |
| 05/14/2009 | WO2009059448A1 Styrene-acid derivative and use in manufacturing blood-vessel targeted-agent drugs |
| 05/14/2009 | WO2009042444A3 Methods and compounds for treating retinol-related diseases |
| 05/14/2009 | WO2009033807A3 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 05/14/2009 | US20090124676 Substituted cyclopentanes having prostaglandin activity |
| 05/14/2009 | US20090124674 Method for treating congestive heart failure |
| 05/14/2009 | US20090124673 Method for treating diabetic nephropathy |
| 05/14/2009 | US20090124645 Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels |
| 05/14/2009 | US20090124565 comprising an oligonucleotide and cetalkonium chloride (CKC) also called Benzyl n-hexadecyl dimethylammonium chloride wherein the ratio of CKC to mers of the oligonucleotide is below 0.55; prevention, treatment or relief of eye, lung, and/or respiratory tract conditions |
| 05/14/2009 | US20090123379 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 05/14/2009 | US20090123375 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration |
| 05/14/2009 | CA2705150A1 Substituted cyclopentanes having prostaglandin activity |
| 05/14/2009 | CA2705050A1 Compositions for the treatment and prevention of eyelid swelling |
| 05/14/2009 | CA2704973A1 Anti-factor b antibodies and their uses |
| 05/14/2009 | CA2704222A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 05/13/2009 | EP2057128A2 Therapeutic substituted hydantoins and related compounds |
| 05/13/2009 | EP2057122A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor |
| 05/13/2009 | EP2056831A2 Use of pkc inhibitors in particular indolylmaleimide derivatives in ocular diseases |
| 05/13/2009 | EP2056809A1 Ophthalmic percutaneous absorption type preparation |
| 05/13/2009 | EP2056804A1 Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases |
| 05/13/2009 | EP2056799A2 Compositions and methods for treating or preventing glaucoma or progression thereof |
| 05/13/2009 | EP1912957A4 Ep4 receptor agonist, compositions and methods thereof |
| 05/13/2009 | EP1753434B1 Enhanced bimatoprost ophthalmic solution |
| 05/13/2009 | EP1178818A4 A stable composition comprising epidermal growth factor as an active ingredient |
| 05/13/2009 | CN101432013A Use of antisecretory factors for treating intraocular hypertension |
| 05/13/2009 | CN101432009A Preventative treatment and remission of allergic diseases |
| 05/13/2009 | CN101432000A Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
| 05/13/2009 | CN101431993A Use of DHA and ARA in the preparation of a composition for regulating gene expression |
| 05/13/2009 | CN101428046A Novel broad spectrum antiphlogistic pain-easing externally used medicament |
| 05/13/2009 | CN101428032A Gentamicin gel rubber preparation |
| 05/13/2009 | CN101428000A Azithromycin auristillae and method of producing the same |
| 05/13/2009 | CN101427997A Eye drop with anti-cornea rebirth blood vessel function and preparation method thereof |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/13/2009 | CN100486642C 疫苗 Vaccine |
| 05/13/2009 | CN100486630C Medicine composition for treating eye disease, and its use |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486456C Health-care food used for reliefing eyestrain, and its preparing method |
| 05/12/2009 | US7531651 e.g. 4-({[({[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}amino)carbonyl]amino}methyl)benzamide benzenesulfonate dihydrate; chemokine (C-C motif) receptor antagonist; antiinflammatory agent; asthma, rhinitis |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | CA2475302C Controlled synthesis of ziprasidone and compositions thereof |
| 05/12/2009 | CA2387398C Novel combination of loteprednol and antihistamines |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2348890C Use of staurosporine derivatives for treating ocular neovascular diseases |
| 05/12/2009 | CA2315829C Angiostatic agents and compositions for controlling ocular hypertension |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/07/2009 | WO2009058958A2 Lipoxin a4 protection for cornea endothelial cells |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009035534A3 Treatment of ischemic eye disease by the systematic pharmaceutical activation of hypoxia inducible factor (hif) |
| 05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
| 05/07/2009 | US20090118322 Agent for repairing corneal sensitivity containing amide compound |
| 05/07/2009 | US20090118299 Agent for prevention or treatment of glaucoma |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118262 Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery |
| 05/07/2009 | US20090118247 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 05/07/2009 | US20090118246 Therapeutic ophthalmic compositions containing retinal friendly recpients and related methods |
| 05/07/2009 | US20090118243 Compositions and methods for the treatment of ophthalmic conditions |
| 05/07/2009 | US20090118228 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117171 Compositions and methods for treatment of macular degeneration and related conditions |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117119 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 05/07/2009 | US20090117098 Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma |
| 05/07/2009 | CA2705465A1 Lipoxin a4 protection for cornea endothelial cells |
| 05/07/2009 | CA2704337A1 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |